Whole-exome sequencing studies of nonfunctioning pituitary adenomas.
CONTEXT: The tumorigenic role of genetic abnormalities in sporadic pituitary nonfunctioning adenomas (NFAs), which usually originate from gonadotroph cells, is unknown. OBJECTIVE: The objective of the study was to identify somatic genetic abnormalities in sporadic pituitary NFAs. DESIGN: Whole-exome...
| Principais autores: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Journal article |
| Idioma: | English |
| Publicado em: |
Endocrine Society
2013
|
| _version_ | 1826291652419911680 |
|---|---|
| author | Newey, P Nesbit, M Rimmer, A Head, R Gorvin, C Attar, M Gregory, L Wass, J Buck, D Karavitaki, N Grossman, A McVean, G Ansorge, O Thakker, R |
| author_facet | Newey, P Nesbit, M Rimmer, A Head, R Gorvin, C Attar, M Gregory, L Wass, J Buck, D Karavitaki, N Grossman, A McVean, G Ansorge, O Thakker, R |
| author_sort | Newey, P |
| collection | OXFORD |
| description | CONTEXT: The tumorigenic role of genetic abnormalities in sporadic pituitary nonfunctioning adenomas (NFAs), which usually originate from gonadotroph cells, is unknown. OBJECTIVE: The objective of the study was to identify somatic genetic abnormalities in sporadic pituitary NFAs. DESIGN: Whole-exome sequencing was performed using DNA from 7 pituitary NFAs and leukocyte samples obtained from the same patients. Somatic variants were confirmed by dideoxynucleotide sequencing, and candidate driver genes were assessed in an additional 24 pituitary NFAs. RESULTS: Whole-exome sequencing achieved a high degree of coverage such that approximately 97% of targeted bases were represented by more than 10 base reads; 24 somatic variants were identified and confirmed in the discovery set of 7 pituitary NFAs (mean 3.5 variants/tumor; range 1-7). Approximately 80% of variants occurred as missense single nucleotide variants and the remainder were synonymous changes or small frameshift deletions. Each of the 24 mutations occurred in independent genes with no recurrent mutations. Mutations were not observed in genes previously associated with pituitary tumorigenesis, although somatic variants in putative driver genes including platelet-derived growth factor D (PDGFD), N-myc down-regulated gene family member 4 (NDRG4), and Zipper sterile-α-motif kinase (ZAK) were identified; however, DNA sequence analysis of these in the validation set of 24 pituitary NFAs did not reveal any mutations indicating that these genes are unlikely to contribute significantly in the etiology of sporadic pituitary NFAs. CONCLUSIONS: Pituitary NFAs harbor few somatic mutations consistent with their low proliferation rates and benign nature, but mechanisms other than somatic mutation are likely involved in the etiology of sporadic pituitary NFAs. |
| first_indexed | 2024-03-07T03:02:37Z |
| format | Journal article |
| id | oxford-uuid:b17780e5-e7d9-4891-ba3c-c67b3dd3d9d7 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T03:02:37Z |
| publishDate | 2013 |
| publisher | Endocrine Society |
| record_format | dspace |
| spelling | oxford-uuid:b17780e5-e7d9-4891-ba3c-c67b3dd3d9d72022-03-27T04:04:21ZWhole-exome sequencing studies of nonfunctioning pituitary adenomas.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b17780e5-e7d9-4891-ba3c-c67b3dd3d9d7EnglishSymplectic Elements at OxfordEndocrine Society2013Newey, PNesbit, MRimmer, AHead, RGorvin, CAttar, MGregory, LWass, JBuck, DKaravitaki, NGrossman, AMcVean, GAnsorge, OThakker, RCONTEXT: The tumorigenic role of genetic abnormalities in sporadic pituitary nonfunctioning adenomas (NFAs), which usually originate from gonadotroph cells, is unknown. OBJECTIVE: The objective of the study was to identify somatic genetic abnormalities in sporadic pituitary NFAs. DESIGN: Whole-exome sequencing was performed using DNA from 7 pituitary NFAs and leukocyte samples obtained from the same patients. Somatic variants were confirmed by dideoxynucleotide sequencing, and candidate driver genes were assessed in an additional 24 pituitary NFAs. RESULTS: Whole-exome sequencing achieved a high degree of coverage such that approximately 97% of targeted bases were represented by more than 10 base reads; 24 somatic variants were identified and confirmed in the discovery set of 7 pituitary NFAs (mean 3.5 variants/tumor; range 1-7). Approximately 80% of variants occurred as missense single nucleotide variants and the remainder were synonymous changes or small frameshift deletions. Each of the 24 mutations occurred in independent genes with no recurrent mutations. Mutations were not observed in genes previously associated with pituitary tumorigenesis, although somatic variants in putative driver genes including platelet-derived growth factor D (PDGFD), N-myc down-regulated gene family member 4 (NDRG4), and Zipper sterile-α-motif kinase (ZAK) were identified; however, DNA sequence analysis of these in the validation set of 24 pituitary NFAs did not reveal any mutations indicating that these genes are unlikely to contribute significantly in the etiology of sporadic pituitary NFAs. CONCLUSIONS: Pituitary NFAs harbor few somatic mutations consistent with their low proliferation rates and benign nature, but mechanisms other than somatic mutation are likely involved in the etiology of sporadic pituitary NFAs. |
| spellingShingle | Newey, P Nesbit, M Rimmer, A Head, R Gorvin, C Attar, M Gregory, L Wass, J Buck, D Karavitaki, N Grossman, A McVean, G Ansorge, O Thakker, R Whole-exome sequencing studies of nonfunctioning pituitary adenomas. |
| title | Whole-exome sequencing studies of nonfunctioning pituitary adenomas. |
| title_full | Whole-exome sequencing studies of nonfunctioning pituitary adenomas. |
| title_fullStr | Whole-exome sequencing studies of nonfunctioning pituitary adenomas. |
| title_full_unstemmed | Whole-exome sequencing studies of nonfunctioning pituitary adenomas. |
| title_short | Whole-exome sequencing studies of nonfunctioning pituitary adenomas. |
| title_sort | whole exome sequencing studies of nonfunctioning pituitary adenomas |
| work_keys_str_mv | AT neweyp wholeexomesequencingstudiesofnonfunctioningpituitaryadenomas AT nesbitm wholeexomesequencingstudiesofnonfunctioningpituitaryadenomas AT rimmera wholeexomesequencingstudiesofnonfunctioningpituitaryadenomas AT headr wholeexomesequencingstudiesofnonfunctioningpituitaryadenomas AT gorvinc wholeexomesequencingstudiesofnonfunctioningpituitaryadenomas AT attarm wholeexomesequencingstudiesofnonfunctioningpituitaryadenomas AT gregoryl wholeexomesequencingstudiesofnonfunctioningpituitaryadenomas AT wassj wholeexomesequencingstudiesofnonfunctioningpituitaryadenomas AT buckd wholeexomesequencingstudiesofnonfunctioningpituitaryadenomas AT karavitakin wholeexomesequencingstudiesofnonfunctioningpituitaryadenomas AT grossmana wholeexomesequencingstudiesofnonfunctioningpituitaryadenomas AT mcveang wholeexomesequencingstudiesofnonfunctioningpituitaryadenomas AT ansorgeo wholeexomesequencingstudiesofnonfunctioningpituitaryadenomas AT thakkerr wholeexomesequencingstudiesofnonfunctioningpituitaryadenomas |